Empowered Patient Podcast

Daniel Cohen, Founder, Pharnext discusses how the French biopharma company is using its artificial intelligence (AI) driven platform to identify drugs that have already been approved which can be used in combination to fight COVID-19.  Dr. Cohen who lead Pharnext as CEO for over a decade has recently left that role to become Chairman of Pharnext's Scientific Advisory Board in order to focus on his true passion--maximizing the potential of Pharnext's Pleotherapy platform. #pharnext #pleotherapy #COVID19 #drugdiscovery #AI Pharnext.com Download the transcript